GLP-3RT 30MG

Triple Incretin Agonist Peptide

Category: Metabolic & Weight Management Peptides

GLP-3-30MG | Form: Lyophilized Powder | Purity: ≥ 99% (HPLC Tested)

For Research Use Only – Not for Human Consumption

Product Overview

GLP-3 is a next-generation synthetic peptide designed as a triple receptor agonist, targeting the GLP-1, GIP, and glucagon receptors simultaneously. This novel incretin-based compound has gained attention for its profound effects on glucose regulation, energy expenditure, and adipose tissue metabolism in preclinical and early clinical research. Researchers use Retatrutide to explore advanced metabolic pathways, obesity interventions, and energy-balance mechanisms.

GLP-3 Research Summary

GLP-3 represents a breakthrough in metabolic research due to its ability to activate three key incretin receptors simultaneously, offering a synergistic approach to improving metabolic function. Its design allows for enhanced glycemic control, appetite regulation, and energy utilization compared to dual-agonist compounds such as tirzepatide.

• Up to 27% body-weight reduction 
• Improved glucose control and insulin sensitivity in obese and diabetic models
• Significant reduction in hepatic fat and improved liver enzyme markers
• Increased energy expenditure through glucagon receptor activation and fat oxidation pathways

The peptide’s extended half-life and triple-receptor activation profile make it an important investigational tool for understanding complex metabolic regulation, energy balance, and weight loss mechanisms.

Applications in Research

• Metabolic and obesity modeling studies
• Insulin sensitivity and glucose regulation research
• Liver fat and lipid metabolism investigations
• Energy expenditure and thermogenesis studies
• Receptor synergy and incretin pathway analysis

For Research Use Only

This peptide is intended solely for laboratory research and analytical purposes. It is not approved for diagnostic, therapeutic, or veterinary use. Researchers must adhere to institutional biosafety standards and appropriate peptide-handling regulations.